.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Find suppliers and generic API sources
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Healthtrust
Chubb
Medtronic
Federal Trade Commission
Cipla
Johnson and Johnson
UBS
Mallinckrodt
Accenture

Generated: June 23, 2017

DrugPatentWatch Database Preview

VOLMAX Drug Profile

« Back to Dashboard

What is the patent landscape for Volmax, and what generic Volmax alternatives are available?

Volmax is a drug marketed by Muro and is included in one NDA.

The generic ingredient in VOLMAX is albuterol sulfate. There are thirty-seven drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.

Summary for Tradename: VOLMAX

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list73
Clinical Trials: see list2
Patent Applications: see list3,425
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VOLMAX at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Muro
VOLMAX
albuterol sulfate
TABLET, EXTENDED RELEASE;ORAL019604-002Dec 23, 1992DISCNNoNo► Subscribe► Subscribe
Muro
VOLMAX
albuterol sulfate
TABLET, EXTENDED RELEASE;ORAL019604-001Dec 23, 1992DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VOLMAX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Muro
VOLMAX
albuterol sulfate
TABLET, EXTENDED RELEASE;ORAL019604-001Dec 23, 19924,751,071► Subscribe
Muro
VOLMAX
albuterol sulfate
TABLET, EXTENDED RELEASE;ORAL019604-001Dec 23, 19924,851,229► Subscribe
Muro
VOLMAX
albuterol sulfate
TABLET, EXTENDED RELEASE;ORAL019604-002Dec 23, 19924,751,071► Subscribe
Muro
VOLMAX
albuterol sulfate
TABLET, EXTENDED RELEASE;ORAL019604-001Dec 23, 19924,777,049► Subscribe
Muro
VOLMAX
albuterol sulfate
TABLET, EXTENDED RELEASE;ORAL019604-002Dec 23, 19924,851,229► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Novartis
Harvard Business School
McKesson
Julphar
AstraZeneca
Cerilliant
Healthtrust
Mallinckrodt
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot